Compound Summary
L-lysine
Compound Information
L-lysine
Compound Name: | L-lysine |
Compound CID: | 5962 |
Synonyms: | L-lysine lysine 56-87-1 lysine acid h-Lys-oh More... |
Iupac Name: | (2S)-2,6-diaminohexanoic acid |
InChI: | InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1 |
InChIKey: | KDXKERNSBIXSRK-YFKPBYRVSA-N |
Canonical Smiles: | C(CCN)CC(C(=O)O)N |
Isomeric Smiles: | C(CCN)C[C@@H](C(=O)O)N |
Molecular Weight: | 146.19 |
Molecular Formula: | C6H14N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-lysine
Molecular Weight: | 146.19 |
Molecular Formula: | C6H14N2O2 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 10 |
Complexity: | 106 |
Synonyms
L-lysine
| L-lysine | L-lysine |
|---|---|
L-lysine |
lysine |
56-87-1 |
lysine acid |
h-Lys-oh |
(S)-Lysine |
Aminutrin |
(2S)-2,6-diaminohexanoic acid |
L-(+)-Lysine |
alpha-Lysine |
Poly-L-lysine |
(S)-2,6-Diaminohexanoic acid |
Hydrolysin |
Lysinum Latin |
L-lys |
Lisina Spanish |
(S)-2,6-Diaminocaproic acid |
L-Norleucine, 6-amino- |
Lysine, L- |
Lysinum |
(S)-alpha,epsilon-Diaminocaproic acid |
Lysine USAN:INN |
LYS (IUPAC abbreviation) |
L-2,6-Diaminocaproic acid |
lysin |
Hexanoic acid, 2,6-diamino-, (S)- |
lys |
a-Lysine |
2,6-Diaminohexanoic acid, (S)- |
L-Lysin |
BRN 1722531 |
25104-18-1 |
CHEBI:18019 |
AI3-26523 |
6-ammonio-L-norleucine |
12798-06-0 |
L-Lysine base |
MFCD00064433 |
HSDB 2108 |
L-2,6-Diaminocaproate |
Lisina |
L-LYSINE, MONOACETATE |
(+)-S-Lysine |
3H-Lysine |
2,6-diaminohexanoate |
(S)-(+)-Lysine |
EINECS 200-294-2 |
lysina |
L-Lysine, labeled with tritium |
Ketporofen lysine |
L-aLysine |
.alpha.-Lysine |
1ozv |
1yxd |
3h-l-lysine |
6-amino-Aminutrin |
NCGC00164527-01 |
Poly-(L-lysine) |
H-Lys |
(-)-lysine |
6-amino-L-Norleucine |
a,e-Diaminocaproic acid |
Lysine (USAN/INN) |
Alpha-poly-(L-lysine) |
L-2,6-Diainohexanoate |
(S)-a,e-Diaminocaproate |
DSSTox_CID_3232 |
L-Lysine, >=97% |
bmse000043 |
bmse000914 |
Epitope ID:136017 |
(S)-2,6-Diaminohexanoate |
L-2,6-Diainohexanoic acid |
CHEMBL8085 |
DSSTox_RID_76935 |
DSSTox_GSID_23232 |
GTPL724 |
(S)-2,6-diamino-Hexanoate |
(S)-a,e-Diaminocaproic acid |
4-04-00-02717 (Beilstein Handbook Reference) |
L-Lysine, analytical standard |
L-Lysine, >=98%, FG |
DTXSID6023232 |
(S)-2,6-diamino-Hexanoic acid |
L-Lysine, >=98% (TLC) |
BDBM217367 |
(2S)-2,6-Diamino-hexanoic acid |
ACT02654 |
HY-N0469 |
L-H2N(CH2)4CH(NH2)COOH |
ZINC1532522 |
Tox21_112158 |
Ethyl3,5-dichloro-4-propoxybenzoate |
s5630 |
.alpha.,.epsilon.-Diaminocaproic acid |
AKOS006239081 |
AKOS015855172 |
CCG-266180 |
CS-W019758 |
DB00123 |
EBD2198138 |
MCULE-3226089160 |
CAS-56-87-1 |
L-Lysine solution, purum, 50% in H2O |
NCGC00166296-02 |
20166-34-1 |
AC-14492 |
AS-11733 |
(S)-.alpha.,.epsilon.-Diaminocaproic acid |
AB0010643 |
L-Lysine, crystallized, >=98.0% (NT) |
AM20100376 |
L0129 |
L-Lysine, Vetec(TM) reagent grade, >=98% |
A20652 |
C00047 |
D02304 |
59617-EP2272516A2 |
59617-EP2281821A1 |
59617-EP2295436A1 |
59617-EP2298762A2 |
59617-EP2298773A1 |
59617-EP2301919A1 |
59617-EP2308828A2 |
59617-EP2308852A1 |
064L433 |
A904498 |
A919375 |
J-521651 |
(S)-2,6-Diaminocaproic acid;(S)-(+)-Lysine;Lysine |
Q20816880 |
F0001-1472 |
UNII-0O72R8RF8A component KDXKERNSBIXSRK-YFKPBYRVSA-N |
UNII-AI4RT59273 component KDXKERNSBIXSRK-YFKPBYRVSA-N |
UNII-K3Z4F929H6 component KDXKERNSBIXSRK-YFKPBYRVSA-N |
UNII-N7U7BXP2OI component KDXKERNSBIXSRK-YFKPBYRVSA-N |
0013CD6B-1671-4369-B1BE-F531611E50C7 |
Experimental Data
L-lysine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | mM | 8.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 7.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 10.000000000000000 | mM | 6.000000000000000 | S | N2 | 25643626 | Active |
Experimental Data Visualization
L-lysine
Statistics Data
L-lysine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 8.000000000000000 | 1 | 3 |
Statistics Data Visualization
L-lysine
